Transactions
Showing 28-36 of 969 items
-
UCB
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
-
Telemos Capital
Exclusive Financial Advisor (Buy side)
-
US$46m
TELA Bio
Joint Bookrunner (Follow-On Offering)
-
US$207m
CeriBell
Co-Manager (IPO)
-
VisiQuate
Financial Advisor to VisiQuate on its Acquisition by Accel-KKR
-
United Language Group
Financial Advisor to United Language Group on its Sale to Propio
-
Sam Brown
Financial Advisor to Sam Brown Inc. on its Sale to Blue Matter
-
Adfire Health
Financial Advisor to Adfire Health on its Sale to Health Union
-
PharmaForceIQ
Financial Advisor to PharmaForceIQ on its Significant Investment from Eir Partners
